Company · Montreal, Quebec, Canada
Linson Pharma Co.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 18
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 16
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| LIN-AMOX - CAP 250MGStatus since May 2006 | 02181487 | Cancelled Post Market | |
| LIN-AMOX - CAP 500MGStatus since May 2006 | 02181495 | Cancelled Post Market | |
| LIN-AMOX - PWS 125MG/5MLStatus since May 2006 | 02181509 | Cancelled Post Market | |
| LIN-AMOX - PWS 250MG/5MLStatus since May 2006 | 02181517 | Cancelled Post Market | |
| LIN-FOSINOPRILStatus since Jul 2008 | 02242733 | Cancelled Post Market | |
| LIN-FOSINOPRILStatus since Jul 2008 | 02242734 | Cancelled Post Market | |
| LIN-NEFAZODONEStatus since Nov 2003 | 02237397 | Cancelled Post Market | |
| LIN-NEFAZODONEStatus since Nov 2003 | 02237398 | Cancelled Post Market | |
| LIN-NEFAZODONEStatus since Nov 2003 | 02237399 | Cancelled Post Market | |
| LIN-NEFAZODONEStatus since Nov 2003 | 02237400 | Cancelled Post Market | |
| LIN-PRAVASTATINStatus since May 2006 | 02237373 | Cancelled Post Market | |
| LIN-PRAVASTATINStatus since May 2006 | 02237374 | Cancelled Post Market | |
| LIN-PRAVASTATINStatus since May 2006 | 02237375 | Cancelled Post Market | |
| LINBUSPIRONEStatus since May 2006 | 02176122 | Cancelled Post Market | |
| LINMEGESTROL - TAB 160MGStatus since May 2006 | 02176106 | Cancelled Post Market | |
| LINMEGESTROL - TAB 40MGStatus since Aug 2004 | 02176092 | Cancelled Post Market | |
| LINSOTALOL - TAB 80MGStatus since May 2006 | 02170833 | Cancelled Post Market | |
| LINSOTALOL -TAB 160MGStatus since May 2006 | 02170841 | Cancelled Post Market |
Notices of Compliance
Newest first.
- LIN-PRAVASTATINApril 4, 2003 · NOC 3470 · Supplement to a New Drug Submission (SNDS)
- LIN WARFARINMay 1, 2002 · NOC 794 · Supplement to a New Drug Submission (SNDS)
- ENDANTADINEJanuary 2, 2002 · NOC 236 · New Drug Submission (NDS)
- LIN WARFARINJanuary 2, 2002 · NOC 796 · New Drug Submission (NDS)
- LIN-NEFAZODONEApril 26, 2001 · NOC 2477 · Supplement to a New Drug Submission (SNDS)
- ZIMAMOXJanuary 18, 2001 · NOC 1698 · New Drug Submission (NDS)
- LIN-BUTORPHANOL NSOctober 5, 2000 · NOC 988 · New Drug Submission (NDS)
- LIN-FOSINOPRILAugust 17, 2000 · NOC 1158 · New Drug Submission (NDS)
- LIN-PRAVASTATINJune 22, 2000 · NOC 1406 · Supplement to a New Drug Submission (SNDS)
- LIN-NEFAZODONEFebruary 19, 1998 · NOC 3099 · New Drug Submission (NDS)
- LIN-PRAVASTATINFebruary 13, 1998 · NOC 3130 · New Drug Submission (NDS)
- LINMEGESTROLMay 29, 1997 · NOC 3934 · Supplement to a New Drug Submission (SNDS)
- LIN-AMOXSeptember 15, 1995 · NOC 4859 · New Drug Submission (NDS)
- LINBUSPIRONEJuly 26, 1995 · NOC 4882 · New Drug Submission (NDS)
- LINMEGESTROL TABLETSJuly 26, 1995 · NOC 5141 · New Drug Submission (NDS)
- LINSOTALOLJune 13, 1995 · NOC 5246 · New Drug Submission (NDS)